基于库马林的乙胆酶抑制剂的开发:合成,生物评估和计算模拟
Nouran E Emam1, Rana H Refaey1, Mohamed K El-Ashrey2
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, October University for Modern Sciences and Arts University (MSA), Giza, Egypt.
新的库马林衍生物对阿尔茨海默病的标,包括乙胆酶和GSK-3β,表现出强大的多模式活性. 衍生品10f已成为阿尔茨海默病治疗的有前途的化合物.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药物发现 药物发现 药物发现
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特征是粉样质斑块和神经纤维状的积累.
- 目前的治疗方法可以缓解症状,但不能阻止疾病的进展,因此需要开发新的治疗策略.
- 针对AD病变发生的多种途径的多式疗法被认为是一种有前途的方法.
研究的目的:
- 设计,合成和评估基于库马林的新型衍生物作为潜在的多式抗阿尔茨海默症药物.
- 调查这些衍生物对涉及AD的关键酶的抑制潜力,包括乙胆化酶 (AChE),丁胆化酶 (BuChE) 和糖原合成酶激酶-3β (GSK-3β).
- 评估铁化能力,探索最强效化合物的分子相互作用.
主要方法:
- 新型库马林衍生物 (化合物5,6a-c和10a-j) 的合成,然后通过光谱分析进行结构确认.
- 对抗ACHE,BuChE和GSK-3β的酶抑制试验的体外生物评估.
- 在体外测定铁化能力.
- 分子对接研究和分子动力学模拟以阐明结合相互作用和稳定性.
主要成果:
- 几种合成库马林衍生物对AChE表现出显著的抑制活性,其中10c,10d,10f和10i化合物表现出纳米分子功效,优于参考药物donepezil.
- 衍生品10f在纳米分子范围内表现出明显的对BuChE和GSK-3β的抑制,超过了参考抑制剂.
- 衍生品10f也显示出显著的铁合活性.
- 分子对接和动力学模拟确定了衍生品10f作为具有有利结合相互作用和复杂稳定性的有希望的领先候选者.
结论:
- 设计的基于库马林的衍生品代表了阿尔茨海默病治疗的有前途的多式联络剂类.
- 衍生品10f被强调为一种化合物,因为它对关键的AD标和有利的药物动力学特性具有强大和广泛的抑制性.
- 对10f衍生物的进一步开发可能会导致针对阿尔茨海默病的新疗法策略.
更多相关视频
05:44Author Spotlight: Developing Acetyl-Click Assay for HAT1 Inhibitor Screening
Published on: January 26, 2024
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
